abiraterone mylan
mylan ireland limited - abirateronacetat - prostata neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
vemlidy 25 mg
orifarm as - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg
vemlidy 25 mg
abacus medicine a/s - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg
jevtana 60 mg
orifarm as - kabazitaksel - konsentrat og væske til infusjonsvæske, oppløsning - 60 mg
carepen vet 600 mg
vetcare limited - benzylpenicillinprokainmonohydrat - intramammarie, suspensjon - 600 mg
metacam 2.5 mg
orifarm as - meloksikam - tyggetablett - 2.5 mg
metacam 15 mg/ ml
2care4 aps - meloksikam - mikstur, suspensjon - 15 mg/ ml
drytec tm -
ge healthcare b.v. - natriummolybdat mo-99 omdannes til natriumperteknetat tc-99m - radionuklidegenerator